PharVision Advisers »

Hanesbrands shares owned by PharVision Advisers

Quarter-by-quarter ownership of Hanesbrands (HBI) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Hanesbrands

Tip: Access up to 7 years of quarterly data

All positions including Hanesbrands held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hanesbrands by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-03-31 $98k 17k 5.77
2024-12-31 $453k 56k 8.14

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Hanesbrands

BlackRock
Vanguard Group
Loews Corporation
Brandes Investment Partners
State Street Corporation
Goldman Sachs Group
Hanna Zanoni
Allianz Asset Management
Geode Capital Management
D. E. Shaw & Co
Dimensional Fund Advisors
New South Capital Management
CNH Partners
Charles Schwab Investment Management
Jpmorgan Chase & Co

View all funds holding Hanesbrands